About Cobalt Oak
Specialist intelligence for regulated AI clinical software.
Cobalt Oak produces independent regulatory and clinical assessments of AI clinical software startups and scaleups, for investors and corporate teams evaluating a specific company.
What we do
We read the public record so you do not have to.
Cobalt Oak assembles public regulatory, clinical, and market records on a named company and returns a single readable assessment: what is registered and where, under which authorised claim, what evidence exists, and what the record leaves open.
The goal is not to cover every AI company or every digital health company. The focus is intentionally narrow: regulated AI clinical software, where the path from product promise to real-world adoption depends on evidence, compliance, and execution.
Why it exists
AI clinical software needs a different kind of reading.
The records are public.
Registrations, certificates, and registered trials sit in official registries. Anyone can open them. Very few can read them correctly.
Regulated software is different.
In AI clinical software, regulatory pathway, intended use, validation evidence, and market readiness directly shape execution risk.
Decisions have a deadline.
A company under assessment does not wait three weeks. Cobalt Oak returns a full assessment in five working days.
Focus
Built for investors looking at a specific category of health technology.
Cobalt Oak focuses on AI clinical software startups and scaleups, including companies operating in diagnostic AI, clinical decision support, risk prediction, triage, imaging AI, workflow AI, remote monitoring, and related regulated software categories.
This focus is what makes depth possible. Rather than covering the whole of digital health thinly, Cobalt Oak knows one category well enough to read its regulatory record accurately.
Methodology
Public records, read and interpreted.
Regulatory record
Registrations by jurisdiction, product classification, pathway taken, certificates and scope, economic operators.
Clinical record
Registered trials, design and status, enrolment and sites, posted results, and published evidence.
Market record
Geography, segment, company stage, financing visibility, operational status, and commercial presence.
Overall analysis
A written read across the above, plus the specific questions the public record cannot answer.
Sources
Built from public information, not private company claims.
Cobalt Oak uses publicly available sources such as official regulatory and clinical registries, company websites, product pages, clinical publications, and other public materials.
The underlying company base is updated continuously as new public records are identified. Anyone can suggest a correction when information appears incomplete, outdated, or inaccurate.
Leadership
Request a Target Assessment.
Send the company name and your decision timeline. You get an answer within one business day on whether the public record supports a useful assessment — with price and delivery date.
Request a Target AssessmentCobalt Oak assessments are based on publicly available information as of the report date. They are non-binding and do not constitute investment, legal, regulatory, or medical advice.